Tranche Update on Semler Scientific, Inc.'s Equity Buyback Plan announced on March 14, 2022.
November 01, 2022 at 04:08 pm EDT
Share
From July 1, 2022 to September 30, 2022, the company has repurchased 47,458 shares, representing 0.71% for $2.04 million. With this, the company has completed the repurchase of 148,500 shares, representing 2.2% for $4.99 million under the buyback announced on March 14, 2022.
Semler Scientific, Inc. develops, manufactures, and markets products and services that assist in evaluating and treating chronic diseases. The Company provides technology solutions to healthcare providers. The Company's flagship product, QuantaFlo is a four-minute in-office blood flow test. Healthcare providers can use blood flow measurements as part of their examinations of a patientâs vascular condition, including assessments of patients who have vascular disease. QuantaFlo features a sensor clamp that is placed on the toe or finger. Infrared light emitted from the clamp on the dorsal surface of the digit is scattered and reflected by the red blood cells coursing through the area of illumination. Returning light is sensed by the sensor. A blood flow waveform is instantaneously constructed by its proprietary software algorithm. Its customers for QuantaFlo include insurance plans, physician groups, risk assessment groups, hospitals and retailers.
SEMLER SCIENTIFIC, INC. 
